OTC Markets OTCPK - Delayed Quote USD

DNA Brands, Inc. (DNAX)

Compare
0.0001
+0.0001
(0.00%)
As of April 4 at 4:00:00 PM EDT. Market Open.
Loading Chart for DNAX
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0001 x --
  • Ask 0.0001 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0000 - 0.0009
  • Volume 100,000
  • Avg. Volume 1,436,797
  • Market Cap (intraday) 264,056
  • Beta (5Y Monthly) 1.69
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

DNA Brands, Inc. provides energy drinks. It offers products in various flavors, such as cellular citrus zero sugar, cellular citrus, cryo berry, and molecular melon. The company markets its products for retailers, restaurants, bars, and clubs. DNA Brands, Inc. also owns TokenTalk.io, an advisory firm for companies looking to raise money through an ICO. The company is based in Fort Lauderdale, Florida.

www.dnabrandsinc.com

1

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DNAX

View More

Performance Overview: DNAX

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DNAX
50.00%
S&P 500 (^GSPC)
15.11%

1-Year Return

DNAX
87.50%
S&P 500 (^GSPC)
4.06%

3-Year Return

DNAX
99.71%
S&P 500 (^GSPC)
10.95%

5-Year Return

DNAX
99.90%
S&P 500 (^GSPC)
87.75%

Compare To: DNAX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DNAX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    264.06k

  • Enterprise Value

    3.29M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    249.01k

  • Net Income Avi to Common (ttm)

    -1.25M

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    499

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: DNAX

View More

Company Insights: DNAX

Research Reports: DNAX

View More

People Also Watch